UBS Group’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4K | Sell |
12,021
-11,587
|
|
||||
|
2025
Q1 | $37.3K | Sell |
23,608
-72,006
|
|
||||
|
2024
Q4 | $171K | Buy |
95,614
+93,197
|
|
||||
|
2024
Q3 | $14.6K | Buy |
2,417
+852
|
|
||||
|
2024
Q2 | $8.23K | Sell |
1,565
-2,061
|
|
||||
|
2024
Q1 | $30.8K | Sell |
3,626
-1,269
|
|
||||
|
2023
Q4 | $32.3K | Buy |
4,895
+4,730
|
|
||||
|
2023
Q3 | $510 | Sell |
165
-265
|
|
||||
|
2023
Q2 | $1.16K | Sell |
430
-2,824
|
|
||||
|
2023
Q1 | $9.66K | Sell |
3,254
-3,268
|
|
||||
|
2022
Q4 | $16.4K | Buy |
+6,522
|
|
||||
|
2022
Q3 | – | Sell |
-28,551
|
|
||||
|
2022
Q2 | $90K | Sell |
28,551
-2,891
|
|
||||
|
2022
Q1 | $194K | Buy |
31,442
+329
|
|
||||
|
2021
Q4 | $442K | Buy |
31,113
+16,227
|
|
||||
|
2021
Q3 | $119K | Sell |
14,886
-43,154
|
|
||||
|
2021
Q2 | $1.66M | Buy |
58,040
+57,172
|
|
||||
|
2021
Q1 | $25K | Buy |
868
+464
|
|
||||
|
2020
Q4 | $5K | Sell |
404
-2,347
|
|
||||
|
2020
Q3 | $19K | Buy |
+2,751
|
|
||||
|
2020
Q2 | – | Sell |
-1,625
|
|
||||
|
2020
Q1 | $7K | Buy |
1,625
+913
|
|
||||
|
2019
Q4 | $4K | Buy |
+712
|
|
||||
|
2018
Q2 | – | Sell |
-1,590
|
|
||||
|
2018
Q1 | $6K | Buy |
1,590
+1,177
|
|
||||
|
2017
Q4 | $2K | Buy |
+413
|
|
||||
|
2017
Q3 | – | Sell |
-300
|
|
||||
|
2017
Q2 | $3K | Buy |
+300
|
|
||||
|
2016
Q1 | – | Sell |
-52
|
|
||||
|
2015
Q4 | $4K | Buy |
+52
|
|